BDRX – biodexa pharmaceuticals plc - american depositary shares (US:NASDAQ)

News

Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies
Tanner Pharma Group and Biodexa Launch Global Early Access Program for FAP Patients
BDRX: Initiating Coverage of Biodexa Pharmaceuticals; A Deep Value Oncology Platform Built Around Two High-Conviction Areas [Yahoo! Finance]
Biodexa Pharmaceuticals (BDRX) was downgraded by Wall Street Zen from
Preliminary Results for the Year Ended 31 December 2025 [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com